New Era Begins In Korea: Policy Predictions For Biopharma

Doctors’ Dispute, R&D Investment, AI Technology In Focus

 
• By Jung Won Shin
  
Korean flag and medicines
Biopharma Policy Direction In Spotlight After South Korean Election (Shutterstock)

More from Elections

More from South Korea